Scipher Medicine Builds Evidence for Tests Predicting Response to Autoimmune Disease Drugs

Jan 09, 2019

|

Premium

NEW YORK (GenomeWeb) – Scipher Medicine of Boston is hoping to develop molecular signatures that can predict a patient's response to autoimmune disease drugs, pushing precision medicine into areas other than oncology.

The company, which was founded in 2014 by researchers at Northeastern University, Harvard, and Brigham and Women's Hospital, uses a proprietary approach for discovering RNA signatures, which it is applying first to predict response to anti-TNF drugs in rheumatoid arthritis and ulcerative colitis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Search Decisions

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

The Mouse of the Situation

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

Pain Targeted

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

Science Presents Malaria Cell Atlas, More

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Featured White Papers

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

10 Tips to Scale Your Diagnostics Business and Grow Your Test Portfolio Globally

Build vs. Buy? 6 Questions to Consider When Investigating Clinical Diagnostics Informatics Solutions

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Aug

29

Featured Webinar

Biobanking at Scale to Support Precision Medicine

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.

Sep

16

Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Sep

18

Featured Webinar

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Oct

03

Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Menu